Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone Sensitizes Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer

Research Square(2023)10.21203/rs.3.rs-2909446/v1Source: DataRank Database

pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone Sensitizes Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer is a research paper published in Research Square (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone and Sensitize free Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer Cells and Mouse Model · Harvard Dataverse

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (22)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Archana De,Arnab Ghosh ORCID,Raj Shankar Hazra ORCID,Pratyusha Ghosh,Snigdha Banerjee ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4376603876

National Institutes of Health

Grant: 5P20GM109024-04

Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer

greenLicense: cc-by

repositoryhttps://www.researchsquare.com/article/rs-2909446/latest.pdf

publisherhttps://www.researchsquare.com/article/rs-2909446/v1

publisherhttps://www.researchsquare.com/article/rs-2909446/v1.html

repositoryhttps://doi.org/10.21203/rs.3.rs-2909446/v1

Fields of Study

Pancreatic and Hepatic Oncology ResearchPhagocytosis and Immune RegulationCancer, Hypoxia, and Metabolism02 engineering and technology0210 nano-technology

Keywords

NanocarriersGemcitabineMAPK/ERK pathwayPancreatic cancerCancer researchIn vivoTumor microenvironmentChemistryDrugPharmacologyCancerMedicineSignal transductionInternal medicineBiologyTumor cellsBiochemistry

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

pH-responsive Targeted nanoparticles release ERK-inhibitor in the hypoxic zone and Sensitize free Gemcitabine in Mutant K-Ras-addicted Pancreatic Cancer Cells and Mouse Model

10.7910/dvn/fxketoHarvard Dataverse